Drug Shortage Report for METHOTREXATE INJECTION USP
| Report ID | 239727 |
| Drug Identification Number | 02182971 |
| Brand name | METHOTREXATE INJECTION USP |
| Common or Proper name | METHOTREXATE 500MG/20ML |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | METHOTREXATE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20ML VIAL |
| ATC code | L01BA |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-11-29 |
| Actual start date | |
| Estimated end date | 2025-02-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-11-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-11-30 | English | Compare |
| v2 | 2024-10-09 | French | Compare |
| v1 | 2024-10-09 | English | Compare |
Showing 1 to 3 of 3